Market capitalization | JPY317.62b |
Enterprise Value | JPY548.45b |
P/E (TTM) P/E ratio | 6.60 |
EV/Sales (TTM) EV/Sales | 0.94 |
P/S ratio (TTM) P/S ratio | 0.54 |
P/B ratio (TTM) P/B ratio | 0.88 |
Dividend yield | 5.01% |
Last dividend (FY26) | JPY60.00 |
Revenue growth (TTM) Revenue growth | 5.10% |
As a Free StocksGuide user, you can view scores for all 6,786 stocks worldwide.
7 Analysts have issued a Daicel forecast:
7 Analysts have issued a Daicel forecast:
Mar '25 |
+/-
%
|
||
Revenue | 586,531 586,531 |
5%
5%
|
|
Gross Profit | 164,746 164,746 |
3%
3%
|
|
EBITDA | 102,384 102,384 |
7%
7%
|
EBIT (Operating Income) EBIT | 61,011 61,011 |
2%
2%
|
Net Profit | 49,481 49,481 |
11%
11%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Medical and Healthcare Business, Smart Business, Safety Business, Materials Business, Engineering Plastics Business and Others. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.
Head office | Japan |
CEO | Yasuhiro Sakaki |
Founded | 1919 |
Website | www.daicel.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.